Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to ...

After 500 years, scientists have finally decoded a heart structure first sketched by Leonardo da Vinci, linking it to ...

The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...

Abstract: Ultrasonic attenuation in bone in vivo is generally measured using a through-transmission method at the calcaneus. Although attenuation in calcaneus has been demonstrated to be a useful ...

Glucocorticoid-induced osteoporosis (GIOP) remains a major clinical challenge, affecting up to half of patients receiving long-term glucocorticoid ...

Glucocorticoid-induced osteoporosis (GIOP) remains a major clinical challenge, affecting up to half of patients receiving long-term glucocorticoid therapy. Excessive oxidative stress and impaired ...

Spinal implant technology company Curiteva will construct a 45,000 sq ft Innovation Center on its Alabama HQ site.

Healthy mice receiving injections of nerve growth factor (NGF) into their knee joints developed multiple joint abnormalities ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, ...

The final judgment, if upheld, would entitle Sight Sciences to ongoing royalties at a rate of 10% of revenue for each Hydrus sold for the period after entry of the final judgment through the ...

Zimmer Biomet’s G7 TM Acetabular System, an implant for primary and revision hip replacement surgeries, has received FDA 510(k) clearance. The system combines trabecular metal technology, an ...